J&J unit completes SterilMed buy

Johnson & Johnson's ($JNJ) Ethicon Endo-Surgery unit has closed its acquisition of Maple Grove, MN-based SterilMed, which reprocesses and remanufactures single-use medical devices. SterilMed will still operate as a standalone company focused on growing the market for single-use medical device reprocessing.

"Reprocessing has gained widespread acceptance and we will work to support SterilMed in meeting growing demand from customers," said Karen Licitra, company group chairman and worldwide franchise chairman for EES, in a statement. "Together we will be able to continue meeting clinicians' needs for high-performance medical devices, while also offering quality, cost-effective alternatives for hospitals to consider in order to help save money and reduce waste."

In a separate statement, SterilMed announced it has appointed Mike Gustafson as company president. He succeeds Brian Sullivan, who plans to retire following a transition period.

Gustafson worked most recently as the general manager for the worldwide EES sedation systems business since 2004. He also held positions in sales, marketing, education and business development at J&J's EES and Ethicon units in the U.S. and Asia Pacific regions.

- see the EES release
- get the release on Gustafson

Suggested Articles

The FDA has authorized its first COVID-19 antibody test for use in doctors' offices, urgent care centers and emergency rooms.

The clinical testing giant LabCorp will now begin rolling out a blood test for lung cancer developed by Resolution Bioscience.

Cognoa aims to equip pediatricians with an AI-powered app that can spot the signs of autism, allowing them to diagnose in the doctor's office.